{"product_id":"products-resmed-aircurve-11","title":"Resmed Aircurve 11","description":"\u003cp\u003eFor the next-level therapy experience\u003cbr\u003eFor patients who benefit from pressure support\u003c\/p\u003e\n\u003cp\u003eThe AirCurve 11 delivers bilevel therapy with adaptive pressure support designed to stabilise breathing and personalise therapy for patients with CSA (Central Sleep Apnea), OSA (Obstructive Sleep Apnea), mixed apneas, or periodic breathing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAirCurve 11 highlights\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAirCurve™ 11 helps deliver improved therapy outcomes through proven algorithms and the personalised features of the Air11™ platform, underpinned by bilevel therapy providing higher pressure on inhalation (IPAP) and lower pressure on exhalation (EPAP)\u003c\/p\u003e\n\u003cp\u003eSleek, modern design helps reduce the stigma of having a PAP device on \u003cbr\u003ethe nightstand.\u003c\/p\u003e\n\u003cp\u003eTouchscreen makes navigating settings simple and intuitive.\u003c\/p\u003e\n\u003cp\u003eIntegrated cellular and Bluetooth® communication\u003cbr\u003eCellular connectivity≠ enables secure and automated data transmission to the \u003cbr\u003ecloud for access in AirView and myAir. Bluetooth connectivity to myAir assists \u003cbr\u003ewith device setup for a more interactive therapy experience\u003c\/p\u003e\n\u003cp\u003eIntegrated heated humidifier Can be automatically controlled through the Climate Control feature or manually set by the user.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMost suitable for treating central sleep apnea\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eStandard therapies are often unable to fully normalise breathing for patients with \u003cbr\u003epauses in breathing due to the absence of respiratory efforts. These patients may \u003cbr\u003epresent with central sleep apnea, obstructive sleep apnea, mixed apneas or periodic breathing, leading to discomfort and arousals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow the ASV algorithm works\u003c\/strong\u003e \u003c\/p\u003e\n\u003cp\u003eLeveraging Breath Phase Mapping technology, the algorithm rapidly increases pressure support in response to minute ventilation decrease to maintain \u003cbr\u003eit at the target.\u003c\/p\u003e\n\u003cp\u003eThe algorithm gradually reduces pressure support to a comfortable minimum once breathing is stabilised to prevent over-ventilation or hypocapnia.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey elements of the algorithm\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003eASV and ASVAuto\u003c\/p\u003e\n\u003cp\u003e1. Adaptive pressure support\u003c\/p\u003e\n\u003cp\u003eDesigned to counterbalance ventilatory instability, pressure support (PS) auto-adjusts between the Min PS and the Max PS to maintain each patient’s unique minute ventilation target (tidal volume and respiratory rate) while maintaining patient-device synchrony and comfort.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e2. AutoEPAP (ASVAuto only)\u003c\/p\u003e\n\u003cp\u003eAuto-adjusts expiratory positive airway pressure (EPAP) within the allowed range (Min EPAP and Max EPAP) to maintain upper airway patency\u003c\/p\u003e\n\u003cp\u003e3. Auto backup rate\u003c\/p\u003e\n\u003cp\u003eUses breath phase mapping to provide a timed backup rate synchronised with the patient’s own breathing to maintain the target minute ventilation \u003cbr\u003ein the case of apneas.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhen can ASV therapy be prescribed?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGuidelines state that ASV therapy can be prescribed in several clinical \u003cbr\u003esituations. The ERS statement on central sleep apnea, the AASM \u003cbr\u003eguidelines, and various statements confirm that ASV is eligible and \u003cbr\u003emay be useful, effective and safe in these clinical situations:\u003cbr\u003e• Central sleep apnea in heart failure with preserved ejection \u003cbr\u003efraction (LVEF \u0026gt; 45%)\u003cbr\u003e• Central sleep apnea associated with long-term drug therapy without alveolar hypoventilation\u003cbr\u003e• Idiopathic central sleep apnea or Cheyne-Stokes respiration\u003cbr\u003e• Treatment-emergent\/persistent central sleep apnea\u003cbr\u003e• Central sleep apnea after ischemic stroke\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Resmed","offers":[{"title":"Default Title","offer_id":52096110723374,"sku":"39109","price":2795.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0991\/7385\/9630\/files\/resmed-aircurve-11__22176.1779266949.1280.1280.jpg?v=1779645656","url":"https:\/\/mycpap.com.au\/products\/products-resmed-aircurve-11","provider":"MyCPAP","version":"1.0","type":"link"}